S&P 500   4,606.69 (+1.50%)
DOW   35,318.83 (+2.14%)
QQQ   385.68 (+0.67%)
AAPL   165.73 (+2.40%)
MSFT   324.23 (+0.38%)
FB   316.30 (+3.08%)
GOOGL   2,856.84 (+0.59%)
AMZN   3,455.73 (+1.95%)
TSLA   1,004.31 (-1.05%)
NVDA   295.41 (-3.75%)
BABA   121.36 (+8.40%)
NIO   32.01 (-0.44%)
CGC   10.14 (+1.50%)
AMD   137.28 (-4.67%)
GE   96.68 (+4.21%)
MU   82.48 (+1.05%)
T   23.47 (+0.04%)
F   19.33 (+0.99%)
DIS   150.17 (+2.70%)
PFE   52.10 (-4.00%)
AMC   29.26 (+0.86%)
ACB   5.96 (+2.41%)
BA   205.57 (+3.57%)
S&P 500   4,606.69 (+1.50%)
DOW   35,318.83 (+2.14%)
QQQ   385.68 (+0.67%)
AAPL   165.73 (+2.40%)
MSFT   324.23 (+0.38%)
FB   316.30 (+3.08%)
GOOGL   2,856.84 (+0.59%)
AMZN   3,455.73 (+1.95%)
TSLA   1,004.31 (-1.05%)
NVDA   295.41 (-3.75%)
BABA   121.36 (+8.40%)
NIO   32.01 (-0.44%)
CGC   10.14 (+1.50%)
AMD   137.28 (-4.67%)
GE   96.68 (+4.21%)
MU   82.48 (+1.05%)
T   23.47 (+0.04%)
F   19.33 (+0.99%)
DIS   150.17 (+2.70%)
PFE   52.10 (-4.00%)
AMC   29.26 (+0.86%)
ACB   5.96 (+2.41%)
BA   205.57 (+3.57%)
S&P 500   4,606.69 (+1.50%)
DOW   35,318.83 (+2.14%)
QQQ   385.68 (+0.67%)
AAPL   165.73 (+2.40%)
MSFT   324.23 (+0.38%)
FB   316.30 (+3.08%)
GOOGL   2,856.84 (+0.59%)
AMZN   3,455.73 (+1.95%)
TSLA   1,004.31 (-1.05%)
NVDA   295.41 (-3.75%)
BABA   121.36 (+8.40%)
NIO   32.01 (-0.44%)
CGC   10.14 (+1.50%)
AMD   137.28 (-4.67%)
GE   96.68 (+4.21%)
MU   82.48 (+1.05%)
T   23.47 (+0.04%)
F   19.33 (+0.99%)
DIS   150.17 (+2.70%)
PFE   52.10 (-4.00%)
AMC   29.26 (+0.86%)
ACB   5.96 (+2.41%)
BA   205.57 (+3.57%)
S&P 500   4,606.69 (+1.50%)
DOW   35,318.83 (+2.14%)
QQQ   385.68 (+0.67%)
AAPL   165.73 (+2.40%)
MSFT   324.23 (+0.38%)
FB   316.30 (+3.08%)
GOOGL   2,856.84 (+0.59%)
AMZN   3,455.73 (+1.95%)
TSLA   1,004.31 (-1.05%)
NVDA   295.41 (-3.75%)
BABA   121.36 (+8.40%)
NIO   32.01 (-0.44%)
CGC   10.14 (+1.50%)
AMD   137.28 (-4.67%)
GE   96.68 (+4.21%)
MU   82.48 (+1.05%)
T   23.47 (+0.04%)
F   19.33 (+0.99%)
DIS   150.17 (+2.70%)
PFE   52.10 (-4.00%)
AMC   29.26 (+0.86%)
ACB   5.96 (+2.41%)
BA   205.57 (+3.57%)
NASDAQ:IMCC

IM Cannabis Stock Forecast, Price & News

$3.38
-0.06 (-1.74%)
(As of 12/6/2021 01:14 PM ET)
Add
Compare
Today's Range
$3.25
$3.44
50-Day Range
$2.29
$4.30
52-Week Range
$2.26
$11.63
Volume
4,719 shs
Average Volume
197,716 shs
Market Capitalization
$229.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive IMCC News and Ratings via Email

Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter.


IM Cannabis logo

About IM Cannabis

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers strains under the Roma, Dairy Queen, London, Tel Aviv, Paris, and Pandora Box brands; and CBD oil products under the IMC brand. The company also offers its intellectual property related services to the medical cannabis industry. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.

Headlines

Reviewing IM Cannabis (NASDAQ:IMCC) and Bon Natural Life (NYSE:BON)
December 4, 2021 |  americanbankingnews.com
IM Cannabis Sees Unusually Large Options Volume (NASDAQ:IMCC)
November 29, 2021 |  americanbankingnews.com
IM Cannabis Corp. (NASDAQ:IMCC) Short Interest Up 136.9% in November
November 29, 2021 |  americanbankingnews.com
Desjardins Trims IM Cannabis (NASDAQ:IMCC) Target Price to C$9.25
November 17, 2021 |  americanbankingnews.com
Short Interest in IM Cannabis Corp. (NASDAQ:IMCC) Rises By 239.0%
November 16, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IMCC
Fax
N/A
Employees
2,020
Year Founded
N/A

Sales & Book Value

Annual Sales
$11.86 million
Book Value
$2.47 per share

Profitability

Net Income
$-21.42 million
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
63,829,000
Market Cap
$229.29 million
Optionable
Not Optionable

Company Calendar

Today
12/06/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
4/22/2022

MarketRank

Overall MarketRank

1.83 out of 5 stars

Medical Sector

806th out of 1,390 stocks

Medicinals & Botanicals Industry

4th out of 19 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -












IM Cannabis (NASDAQ:IMCC) Frequently Asked Questions

Is IM Cannabis a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for IM Cannabis in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" IM Cannabis stock.
View analyst ratings for IM Cannabis
or view top-rated stocks.

Are investors shorting IM Cannabis?

IM Cannabis saw a increase in short interest in November. As of November 15th, there was short interest totaling 109,200 shares, an increase of 136.9% from the October 31st total of 46,100 shares. Based on an average daily trading volume, of 176,300 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.2% of the company's shares are sold short.
View IM Cannabis' Short Interest
.

When is IM Cannabis' next earnings date?

IM Cannabis is scheduled to release its next quarterly earnings announcement on Friday, April 22nd 2022.
View our earnings forecast for IM Cannabis
.

What price target have analysts set for IMCC?

3 brokers have issued 1 year target prices for IM Cannabis' stock. Their forecasts range from $8.00 to $9.25. On average, they expect IM Cannabis' share price to reach $8.42 in the next twelve months. This suggests a possible upside of 149.0% from the stock's current price.
View analysts' price targets for IM Cannabis
or view top-rated stocks among Wall Street analysts.

Who are IM Cannabis' key executives?

IM Cannabis' management team includes the following people:
  • Mr. Marc Lustig M.B.A., M.Sc., Exec. Chairman (Age 47)
  • Mr. Oren Shuster, CEO & Director
  • Mr. Shai Shemesh, Chief Financial Officer
  • Advocate Yael Harrosh, Gen. Counsel, Corp. Sec. & Bus. Mang.
  • Mr. Richard Balla, CEO & Director of German Operations – Adjupharm GmbH

What is IM Cannabis' stock symbol?

IM Cannabis trades on the NASDAQ under the ticker symbol "IMCC."

Who are IM Cannabis' major shareholders?

IM Cannabis' stock is owned by many different retail and institutional investors. Top institutional shareholders include Wasatch Advisors Inc. (6.43%), K.J. Harrison & Partners Inc (1.99%), AdvisorShares Investments LLC (0.62%), EMC Capital Management (0.38%), Royal Bank of Canada (0.32%) and Psagot Value Holdings Ltd. (0.26%).

Which institutional investors are selling IM Cannabis stock?

IMCC stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Psagot Value Holdings Ltd., Psagot Value Holdings Ltd., and Royal Bank of Canada.

Which institutional investors are buying IM Cannabis stock?

IMCC stock was acquired by a variety of institutional investors in the last quarter, including K.J. Harrison & Partners Inc, EMC Capital Management, AdvisorShares Investments LLC, Cowen AND Company LLC, Jane Street Group LLC, and Gofen & Glossberg LLC IL.

How do I buy shares of IM Cannabis?

Shares of IMCC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IM Cannabis' stock price today?

One share of IMCC stock can currently be purchased for approximately $3.38.

How much money does IM Cannabis make?

IM Cannabis has a market capitalization of $229.29 million and generates $11.86 million in revenue each year. The company earns $-21.42 million in net income (profit) each year or ($0.76) on an earnings per share basis.

How many employees does IM Cannabis have?

IM Cannabis employs 2,020 workers across the globe.

What is IM Cannabis' official website?

The official website for IM Cannabis is www.imcannabis.com.

How can I contact IM Cannabis?

The company can be reached via phone at 972-54-668-7515.


This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.